Global Alpha-1 Antitrypsin Drugs Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Alpha-1 Antitrypsin Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Alpha-1 Antitrypsin Drugs market size is USD million in 2022 from USD 1191.1 million in 2021, with a change of % between 2021 and 2022. The global Alpha-1 Antitrypsin Drugs market size will reach USD 2137.8 million in 2028, growing at a CAGR of 8.7% over the analysis period.
The United States Alpha-1 Antitrypsin Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Alpha-1 Antitrypsin Drugs market, reaching US$ million by the year 2028. As for the Europe Alpha-1 Antitrypsin Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Alpha-1 Antitrypsin Drugs players cover Baxter, CSL Behring, Grifols, and Kamada, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Alpha-1 Antitrypsin Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Alpha-1 Antitrypsin Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Alpha-1 Antitrypsin Drugs market size is USD million in 2022 from USD 1191.1 million in 2021, with a change of % between 2021 and 2022. The global Alpha-1 Antitrypsin Drugs market size will reach USD 2137.8 million in 2028, growing at a CAGR of 8.7% over the analysis period.
The United States Alpha-1 Antitrypsin Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Alpha-1 Antitrypsin Drugs market, reaching US$ million by the year 2028. As for the Europe Alpha-1 Antitrypsin Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Alpha-1 Antitrypsin Drugs players cover Baxter, CSL Behring, Grifols, and Kamada, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Alpha-1 Antitrypsin Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Parenteral
- Inhalation
- Drugstore
- Hospital
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Baxter
- CSL Behring
- Grifols
- Kamada
- Abeona Therapeutics
- Alnylam Pharmaceuticals
- Applied Genetic Technologies Corp
- Arrowhead Research Corporation
- Baxalta
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Alpha-1 Antitrypsin Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Alpha-1 Antitrypsin Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Alpha-1 Antitrypsin Drugs by Country/Region, 2017, 2022 & 2028
2.2 Alpha-1 Antitrypsin Drugs Segment by Type
2.2.1 Parenteral
2.2.2 Inhalation
2.3 Alpha-1 Antitrypsin Drugs Sales by Type
2.3.1 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Alpha-1 Antitrypsin Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Alpha-1 Antitrypsin Drugs Sale Price by Type (2017-2022)
2.4 Alpha-1 Antitrypsin Drugs Segment by Application
2.4.1 Drugstore
2.4.2 Hospital
2.4.3 Others
2.5 Alpha-1 Antitrypsin Drugs Sales by Application
2.5.1 Global Alpha-1 Antitrypsin Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Alpha-1 Antitrypsin Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Alpha-1 Antitrypsin Drugs Sale Price by Application (2017-2022)
3 GLOBAL ALPHA-1 ANTITRYPSIN DRUGS BY COMPANY
3.1 Global Alpha-1 Antitrypsin Drugs Breakdown Data by Company
3.1.1 Global Alpha-1 Antitrypsin Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Company (2020-2022)
3.2 Global Alpha-1 Antitrypsin Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Alpha-1 Antitrypsin Drugs Revenue by Company (2020-2022)
3.2.2 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Alpha-1 Antitrypsin Drugs Sale Price by Company
3.4 Key Manufacturers Alpha-1 Antitrypsin Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Alpha-1 Antitrypsin Drugs Product Location Distribution
3.4.2 Players Alpha-1 Antitrypsin Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ALPHA-1 ANTITRYPSIN DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Alpha-1 Antitrypsin Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Alpha-1 Antitrypsin Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Alpha-1 Antitrypsin Drugs Annual Revenue by Geographic Region
4.2 World Historic Alpha-1 Antitrypsin Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Alpha-1 Antitrypsin Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Alpha-1 Antitrypsin Drugs Annual Revenue by Country/Region
4.3 Americas Alpha-1 Antitrypsin Drugs Sales Growth
4.4 APAC Alpha-1 Antitrypsin Drugs Sales Growth
4.5 Europe Alpha-1 Antitrypsin Drugs Sales Growth
4.6 Middle East & Africa Alpha-1 Antitrypsin Drugs Sales Growth
5 AMERICAS
5.1 Americas Alpha-1 Antitrypsin Drugs Sales by Country
5.1.1 Americas Alpha-1 Antitrypsin Drugs Sales by Country (2017-2022)
5.1.2 Americas Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2022)
5.2 Americas Alpha-1 Antitrypsin Drugs Sales by Type
5.3 Americas Alpha-1 Antitrypsin Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alpha-1 Antitrypsin Drugs Sales by Region
6.1.1 APAC Alpha-1 Antitrypsin Drugs Sales by Region (2017-2022)
6.1.2 APAC Alpha-1 Antitrypsin Drugs Revenue by Region (2017-2022)
6.2 APAC Alpha-1 Antitrypsin Drugs Sales by Type
6.3 APAC Alpha-1 Antitrypsin Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Alpha-1 Antitrypsin Drugs by Country
7.1.1 Europe Alpha-1 Antitrypsin Drugs Sales by Country (2017-2022)
7.1.2 Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2022)
7.2 Europe Alpha-1 Antitrypsin Drugs Sales by Type
7.3 Europe Alpha-1 Antitrypsin Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Alpha-1 Antitrypsin Drugs by Country
8.1.1 Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Type
8.3 Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Alpha-1 Antitrypsin Drugs
10.3 Manufacturing Process Analysis of Alpha-1 Antitrypsin Drugs
10.4 Industry Chain Structure of Alpha-1 Antitrypsin Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Alpha-1 Antitrypsin Drugs Distributors
11.3 Alpha-1 Antitrypsin Drugs Customer
12 WORLD FORECAST REVIEW FOR ALPHA-1 ANTITRYPSIN DRUGS BY GEOGRAPHIC REGION
12.1 Global Alpha-1 Antitrypsin Drugs Market Size Forecast by Region
12.1.1 Global Alpha-1 Antitrypsin Drugs Forecast by Region (2023-2028)
12.1.2 Global Alpha-1 Antitrypsin Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Alpha-1 Antitrypsin Drugs Forecast by Type
12.7 Global Alpha-1 Antitrypsin Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Alpha-1 Antitrypsin Drugs Product Offered
13.1.3 Baxter Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 CSL Behring
13.2.1 CSL Behring Company Information
13.2.2 CSL Behring Alpha-1 Antitrypsin Drugs Product Offered
13.2.3 CSL Behring Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 CSL Behring Main Business Overview
13.2.5 CSL Behring Latest Developments
13.3 Grifols
13.3.1 Grifols Company Information
13.3.2 Grifols Alpha-1 Antitrypsin Drugs Product Offered
13.3.3 Grifols Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Grifols Main Business Overview
13.3.5 Grifols Latest Developments
13.4 Kamada
13.4.1 Kamada Company Information
13.4.2 Kamada Alpha-1 Antitrypsin Drugs Product Offered
13.4.3 Kamada Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Kamada Main Business Overview
13.4.5 Kamada Latest Developments
13.5 Abeona Therapeutics
13.5.1 Abeona Therapeutics Company Information
13.5.2 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Offered
13.5.3 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Abeona Therapeutics Main Business Overview
13.5.5 Abeona Therapeutics Latest Developments
13.6 Alnylam Pharmaceuticals
13.6.1 Alnylam Pharmaceuticals Company Information
13.6.2 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Offered
13.6.3 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Alnylam Pharmaceuticals Main Business Overview
13.6.5 Alnylam Pharmaceuticals Latest Developments
13.7 Applied Genetic Technologies Corp
13.7.1 Applied Genetic Technologies Corp Company Information
13.7.2 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Offered
13.7.3 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Applied Genetic Technologies Corp Main Business Overview
13.7.5 Applied Genetic Technologies Corp Latest Developments
13.8 Arrowhead Research Corporation
13.8.1 Arrowhead Research Corporation Company Information
13.8.2 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Offered
13.8.3 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Arrowhead Research Corporation Main Business Overview
13.8.5 Arrowhead Research Corporation Latest Developments
13.9 Baxalta
13.9.1 Baxalta Company Information
13.9.2 Baxalta Alpha-1 Antitrypsin Drugs Product Offered
13.9.3 Baxalta Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Baxalta Main Business Overview
13.9.5 Baxalta Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Alpha-1 Antitrypsin Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Alpha-1 Antitrypsin Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Alpha-1 Antitrypsin Drugs by Country/Region, 2017, 2022 & 2028
2.2 Alpha-1 Antitrypsin Drugs Segment by Type
2.2.1 Parenteral
2.2.2 Inhalation
2.3 Alpha-1 Antitrypsin Drugs Sales by Type
2.3.1 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Alpha-1 Antitrypsin Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Alpha-1 Antitrypsin Drugs Sale Price by Type (2017-2022)
2.4 Alpha-1 Antitrypsin Drugs Segment by Application
2.4.1 Drugstore
2.4.2 Hospital
2.4.3 Others
2.5 Alpha-1 Antitrypsin Drugs Sales by Application
2.5.1 Global Alpha-1 Antitrypsin Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Alpha-1 Antitrypsin Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Alpha-1 Antitrypsin Drugs Sale Price by Application (2017-2022)
3 GLOBAL ALPHA-1 ANTITRYPSIN DRUGS BY COMPANY
3.1 Global Alpha-1 Antitrypsin Drugs Breakdown Data by Company
3.1.1 Global Alpha-1 Antitrypsin Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Company (2020-2022)
3.2 Global Alpha-1 Antitrypsin Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Alpha-1 Antitrypsin Drugs Revenue by Company (2020-2022)
3.2.2 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Alpha-1 Antitrypsin Drugs Sale Price by Company
3.4 Key Manufacturers Alpha-1 Antitrypsin Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Alpha-1 Antitrypsin Drugs Product Location Distribution
3.4.2 Players Alpha-1 Antitrypsin Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ALPHA-1 ANTITRYPSIN DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Alpha-1 Antitrypsin Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Alpha-1 Antitrypsin Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Alpha-1 Antitrypsin Drugs Annual Revenue by Geographic Region
4.2 World Historic Alpha-1 Antitrypsin Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Alpha-1 Antitrypsin Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Alpha-1 Antitrypsin Drugs Annual Revenue by Country/Region
4.3 Americas Alpha-1 Antitrypsin Drugs Sales Growth
4.4 APAC Alpha-1 Antitrypsin Drugs Sales Growth
4.5 Europe Alpha-1 Antitrypsin Drugs Sales Growth
4.6 Middle East & Africa Alpha-1 Antitrypsin Drugs Sales Growth
5 AMERICAS
5.1 Americas Alpha-1 Antitrypsin Drugs Sales by Country
5.1.1 Americas Alpha-1 Antitrypsin Drugs Sales by Country (2017-2022)
5.1.2 Americas Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2022)
5.2 Americas Alpha-1 Antitrypsin Drugs Sales by Type
5.3 Americas Alpha-1 Antitrypsin Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alpha-1 Antitrypsin Drugs Sales by Region
6.1.1 APAC Alpha-1 Antitrypsin Drugs Sales by Region (2017-2022)
6.1.2 APAC Alpha-1 Antitrypsin Drugs Revenue by Region (2017-2022)
6.2 APAC Alpha-1 Antitrypsin Drugs Sales by Type
6.3 APAC Alpha-1 Antitrypsin Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Alpha-1 Antitrypsin Drugs by Country
7.1.1 Europe Alpha-1 Antitrypsin Drugs Sales by Country (2017-2022)
7.1.2 Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2022)
7.2 Europe Alpha-1 Antitrypsin Drugs Sales by Type
7.3 Europe Alpha-1 Antitrypsin Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Alpha-1 Antitrypsin Drugs by Country
8.1.1 Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Type
8.3 Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Alpha-1 Antitrypsin Drugs
10.3 Manufacturing Process Analysis of Alpha-1 Antitrypsin Drugs
10.4 Industry Chain Structure of Alpha-1 Antitrypsin Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Alpha-1 Antitrypsin Drugs Distributors
11.3 Alpha-1 Antitrypsin Drugs Customer
12 WORLD FORECAST REVIEW FOR ALPHA-1 ANTITRYPSIN DRUGS BY GEOGRAPHIC REGION
12.1 Global Alpha-1 Antitrypsin Drugs Market Size Forecast by Region
12.1.1 Global Alpha-1 Antitrypsin Drugs Forecast by Region (2023-2028)
12.1.2 Global Alpha-1 Antitrypsin Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Alpha-1 Antitrypsin Drugs Forecast by Type
12.7 Global Alpha-1 Antitrypsin Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Alpha-1 Antitrypsin Drugs Product Offered
13.1.3 Baxter Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 CSL Behring
13.2.1 CSL Behring Company Information
13.2.2 CSL Behring Alpha-1 Antitrypsin Drugs Product Offered
13.2.3 CSL Behring Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 CSL Behring Main Business Overview
13.2.5 CSL Behring Latest Developments
13.3 Grifols
13.3.1 Grifols Company Information
13.3.2 Grifols Alpha-1 Antitrypsin Drugs Product Offered
13.3.3 Grifols Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Grifols Main Business Overview
13.3.5 Grifols Latest Developments
13.4 Kamada
13.4.1 Kamada Company Information
13.4.2 Kamada Alpha-1 Antitrypsin Drugs Product Offered
13.4.3 Kamada Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Kamada Main Business Overview
13.4.5 Kamada Latest Developments
13.5 Abeona Therapeutics
13.5.1 Abeona Therapeutics Company Information
13.5.2 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Offered
13.5.3 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Abeona Therapeutics Main Business Overview
13.5.5 Abeona Therapeutics Latest Developments
13.6 Alnylam Pharmaceuticals
13.6.1 Alnylam Pharmaceuticals Company Information
13.6.2 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Offered
13.6.3 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Alnylam Pharmaceuticals Main Business Overview
13.6.5 Alnylam Pharmaceuticals Latest Developments
13.7 Applied Genetic Technologies Corp
13.7.1 Applied Genetic Technologies Corp Company Information
13.7.2 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Offered
13.7.3 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Applied Genetic Technologies Corp Main Business Overview
13.7.5 Applied Genetic Technologies Corp Latest Developments
13.8 Arrowhead Research Corporation
13.8.1 Arrowhead Research Corporation Company Information
13.8.2 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Offered
13.8.3 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Arrowhead Research Corporation Main Business Overview
13.8.5 Arrowhead Research Corporation Latest Developments
13.9 Baxalta
13.9.1 Baxalta Company Information
13.9.2 Baxalta Alpha-1 Antitrypsin Drugs Product Offered
13.9.3 Baxalta Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Baxalta Main Business Overview
13.9.5 Baxalta Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Alpha-1 Antitrypsin Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Alpha-1 Antitrypsin Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Parenteral
Table 4. Major Players of Inhalation
Table 5. Global Alpha-1 Antitrypsin Drugs Sales by Type (2017-2022) & (K Units)
Table 6. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2022)
Table 7. Global Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2022) & ($ million)
Table 8. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2017-2022)
Table 9. Global Alpha-1 Antitrypsin Drugs Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Alpha-1 Antitrypsin Drugs Sales by Application (2017-2022) & (K Units)
Table 11. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2022)
Table 12. Global Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2022)
Table 13. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2017-2022)
Table 14. Global Alpha-1 Antitrypsin Drugs Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Alpha-1 Antitrypsin Drugs Sales by Company (2020-2022) & (K Units)
Table 16. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Company (2020-2022)
Table 17. Global Alpha-1 Antitrypsin Drugs Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Company (2020-2022)
Table 19. Global Alpha-1 Antitrypsin Drugs Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Alpha-1 Antitrypsin Drugs Producing Area Distribution and Sales Area
Table 21. Players Alpha-1 Antitrypsin Drugs Products Offered
Table 22. Alpha-1 Antitrypsin Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Alpha-1 Antitrypsin Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Alpha-1 Antitrypsin Drugs Sales Market Share Geographic Region (2017-2022)
Table 27. Global Alpha-1 Antitrypsin Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Alpha-1 Antitrypsin Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Country/Region (2017-2022)
Table 31. Global Alpha-1 Antitrypsin Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Alpha-1 Antitrypsin Drugs Sales by Country (2017-2022) & (K Units)
Table 34. Americas Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2017-2022)
Table 35. Americas Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2017-2022)
Table 37. Americas Alpha-1 Antitrypsin Drugs Sales by Type (2017-2022) & (K Units)
Table 38. Americas Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2022)
Table 39. Americas Alpha-1 Antitrypsin Drugs Sales by Application (2017-2022) & (K Units)
Table 40. Americas Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2022)
Table 41. APAC Alpha-1 Antitrypsin Drugs Sales by Region (2017-2022) & (K Units)
Table 42. APAC Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2017-2022)
Table 43. APAC Alpha-1 Antitrypsin Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2017-2022)
Table 45. APAC Alpha-1 Antitrypsin Drugs Sales by Type (2017-2022) & (K Units)
Table 46. APAC Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2022)
Table 47. APAC Alpha-1 Antitrypsin Drugs Sales by Application (2017-2022) & (K Units)
Table 48. APAC Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2022)
Table 49. Europe Alpha-1 Antitrypsin Drugs Sales by Country (2017-2022) & (K Units)
Table 50. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2017-2022)
Table 51. Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2017-2022)
Table 53. Europe Alpha-1 Antitrypsin Drugs Sales by Type (2017-2022) & (K Units)
Table 54. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2022)
Table 55. Europe Alpha-1 Antitrypsin Drugs Sales by Application (2017-2022) & (K Units)
Table 56. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Alpha-1 Antitrypsin Drugs
Table 66. Key Market Challenges & Risks of Alpha-1 Antitrypsin Drugs
Table 67. Key Industry Trends of Alpha-1 Antitrypsin Drugs
Table 68. Alpha-1 Antitrypsin Drugs Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Alpha-1 Antitrypsin Drugs Distributors List
Table 71. Alpha-1 Antitrypsin Drugs Customer List
Table 72. Global Alpha-1 Antitrypsin Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Alpha-1 Antitrypsin Drugs Sales Market Forecast by Region
Table 74. Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Alpha-1 Antitrypsin Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Alpha-1 Antitrypsin Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Alpha-1 Antitrypsin Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Alpha-1 Antitrypsin Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Alpha-1 Antitrypsin Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Alpha-1 Antitrypsin Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Alpha-1 Antitrypsin Drugs Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Alpha-1 Antitrypsin Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Alpha-1 Antitrypsin Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Alpha-1 Antitrypsin Drugs Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Alpha-1 Antitrypsin Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 92. Baxter Basic Information, Alpha-1 Antitrypsin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Baxter Alpha-1 Antitrypsin Drugs Product Offered
Table 94. Baxter Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Baxter Main Business
Table 96. Baxter Latest Developments
Table 97. CSL Behring Basic Information, Alpha-1 Antitrypsin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. CSL Behring Alpha-1 Antitrypsin Drugs Product Offered
Table 99. CSL Behring Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. CSL Behring Main Business
Table 101. CSL Behring Latest Developments
Table 102. Grifols Basic Information, Alpha-1 Antitrypsin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Grifols Alpha-1 Antitrypsin Drugs Product Offered
Table 104. Grifols Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Grifols Main Business
Table 106. Grifols Latest Developments
Table 107. Kamada Basic Information, Alpha-1 Antitrypsin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Kamada Alpha-1 Antitrypsin Drugs Product Offered
Table 109. Kamada Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Kamada Main Business
Table 111. Kamada Latest Developments
Table 112. Abeona Therapeutics Basic Information, Alpha-1 Antitrypsin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Offered
Table 114. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Abeona Therapeutics Main Business
Table 116. Abeona Therapeutics Latest Developments
Table 117. Alnylam Pharmaceuticals Basic Information, Alpha-1 Antitrypsin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Offered
Table 119. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Alnylam Pharmaceuticals Main Business
Table 121. Alnylam Pharmaceuticals Latest Developments
Table 122. Applied Genetic Technologies Corp Basic Information, Alpha-1 Antitrypsin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Offered
Table 124. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Applied Genetic Technologies Corp Main Business
Table 126. Applied Genetic Technologies Corp Latest Developments
Table 127. Arrowhead Research Corporation Basic Information, Alpha-1 Antitrypsin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Offered
Table 129. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Arrowhead Research Corporation Main Business
Table 131. Arrowhead Research Corporation Latest Developments
Table 132. Baxalta Basic Information, Alpha-1 Antitrypsin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Baxalta Alpha-1 Antitrypsin Drugs Product Offered
Table 134. Baxalta Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Baxalta Main Business
Table 136. Baxalta Latest Developments
Table 1. Alpha-1 Antitrypsin Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Alpha-1 Antitrypsin Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Parenteral
Table 4. Major Players of Inhalation
Table 5. Global Alpha-1 Antitrypsin Drugs Sales by Type (2017-2022) & (K Units)
Table 6. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2022)
Table 7. Global Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2022) & ($ million)
Table 8. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2017-2022)
Table 9. Global Alpha-1 Antitrypsin Drugs Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Alpha-1 Antitrypsin Drugs Sales by Application (2017-2022) & (K Units)
Table 11. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2022)
Table 12. Global Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2022)
Table 13. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2017-2022)
Table 14. Global Alpha-1 Antitrypsin Drugs Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Alpha-1 Antitrypsin Drugs Sales by Company (2020-2022) & (K Units)
Table 16. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Company (2020-2022)
Table 17. Global Alpha-1 Antitrypsin Drugs Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Company (2020-2022)
Table 19. Global Alpha-1 Antitrypsin Drugs Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Alpha-1 Antitrypsin Drugs Producing Area Distribution and Sales Area
Table 21. Players Alpha-1 Antitrypsin Drugs Products Offered
Table 22. Alpha-1 Antitrypsin Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Alpha-1 Antitrypsin Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Alpha-1 Antitrypsin Drugs Sales Market Share Geographic Region (2017-2022)
Table 27. Global Alpha-1 Antitrypsin Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Alpha-1 Antitrypsin Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Country/Region (2017-2022)
Table 31. Global Alpha-1 Antitrypsin Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Alpha-1 Antitrypsin Drugs Sales by Country (2017-2022) & (K Units)
Table 34. Americas Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2017-2022)
Table 35. Americas Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2017-2022)
Table 37. Americas Alpha-1 Antitrypsin Drugs Sales by Type (2017-2022) & (K Units)
Table 38. Americas Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2022)
Table 39. Americas Alpha-1 Antitrypsin Drugs Sales by Application (2017-2022) & (K Units)
Table 40. Americas Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2022)
Table 41. APAC Alpha-1 Antitrypsin Drugs Sales by Region (2017-2022) & (K Units)
Table 42. APAC Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2017-2022)
Table 43. APAC Alpha-1 Antitrypsin Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2017-2022)
Table 45. APAC Alpha-1 Antitrypsin Drugs Sales by Type (2017-2022) & (K Units)
Table 46. APAC Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2022)
Table 47. APAC Alpha-1 Antitrypsin Drugs Sales by Application (2017-2022) & (K Units)
Table 48. APAC Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2022)
Table 49. Europe Alpha-1 Antitrypsin Drugs Sales by Country (2017-2022) & (K Units)
Table 50. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2017-2022)
Table 51. Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2017-2022)
Table 53. Europe Alpha-1 Antitrypsin Drugs Sales by Type (2017-2022) & (K Units)
Table 54. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2022)
Table 55. Europe Alpha-1 Antitrypsin Drugs Sales by Application (2017-2022) & (K Units)
Table 56. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Alpha-1 Antitrypsin Drugs
Table 66. Key Market Challenges & Risks of Alpha-1 Antitrypsin Drugs
Table 67. Key Industry Trends of Alpha-1 Antitrypsin Drugs
Table 68. Alpha-1 Antitrypsin Drugs Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Alpha-1 Antitrypsin Drugs Distributors List
Table 71. Alpha-1 Antitrypsin Drugs Customer List
Table 72. Global Alpha-1 Antitrypsin Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Alpha-1 Antitrypsin Drugs Sales Market Forecast by Region
Table 74. Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Alpha-1 Antitrypsin Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Alpha-1 Antitrypsin Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Alpha-1 Antitrypsin Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Alpha-1 Antitrypsin Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Alpha-1 Antitrypsin Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Alpha-1 Antitrypsin Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Alpha-1 Antitrypsin Drugs Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Alpha-1 Antitrypsin Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Alpha-1 Antitrypsin Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Alpha-1 Antitrypsin Drugs Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Alpha-1 Antitrypsin Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 92. Baxter Basic Information, Alpha-1 Antitrypsin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Baxter Alpha-1 Antitrypsin Drugs Product Offered
Table 94. Baxter Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Baxter Main Business
Table 96. Baxter Latest Developments
Table 97. CSL Behring Basic Information, Alpha-1 Antitrypsin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. CSL Behring Alpha-1 Antitrypsin Drugs Product Offered
Table 99. CSL Behring Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. CSL Behring Main Business
Table 101. CSL Behring Latest Developments
Table 102. Grifols Basic Information, Alpha-1 Antitrypsin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Grifols Alpha-1 Antitrypsin Drugs Product Offered
Table 104. Grifols Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Grifols Main Business
Table 106. Grifols Latest Developments
Table 107. Kamada Basic Information, Alpha-1 Antitrypsin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Kamada Alpha-1 Antitrypsin Drugs Product Offered
Table 109. Kamada Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Kamada Main Business
Table 111. Kamada Latest Developments
Table 112. Abeona Therapeutics Basic Information, Alpha-1 Antitrypsin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Offered
Table 114. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Abeona Therapeutics Main Business
Table 116. Abeona Therapeutics Latest Developments
Table 117. Alnylam Pharmaceuticals Basic Information, Alpha-1 Antitrypsin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Offered
Table 119. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Alnylam Pharmaceuticals Main Business
Table 121. Alnylam Pharmaceuticals Latest Developments
Table 122. Applied Genetic Technologies Corp Basic Information, Alpha-1 Antitrypsin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Offered
Table 124. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Applied Genetic Technologies Corp Main Business
Table 126. Applied Genetic Technologies Corp Latest Developments
Table 127. Arrowhead Research Corporation Basic Information, Alpha-1 Antitrypsin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Offered
Table 129. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Arrowhead Research Corporation Main Business
Table 131. Arrowhead Research Corporation Latest Developments
Table 132. Baxalta Basic Information, Alpha-1 Antitrypsin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Baxalta Alpha-1 Antitrypsin Drugs Product Offered
Table 134. Baxalta Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Baxalta Main Business
Table 136. Baxalta Latest Developments
LIST OF FIGURES
Figure 1. Picture of Alpha-1 Antitrypsin Drugs
Figure 2. Alpha-1 Antitrypsin Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Alpha-1 Antitrypsin Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Alpha-1 Antitrypsin Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Alpha-1 Antitrypsin Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Parenteral
Figure 10. Product Picture of Inhalation
Figure 11. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type in 2021
Figure 12. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2017-2022)
Figure 13. Alpha-1 Antitrypsin Drugs Consumed in Drugstore
Figure 14. Global Alpha-1 Antitrypsin Drugs Market: Drugstore (2017-2022) & (K Units)
Figure 15. Alpha-1 Antitrypsin Drugs Consumed in Hospital
Figure 16. Global Alpha-1 Antitrypsin Drugs Market: Hospital (2017-2022) & (K Units)
Figure 17. Alpha-1 Antitrypsin Drugs Consumed in Others
Figure 18. Global Alpha-1 Antitrypsin Drugs Market: Others (2017-2022) & (K Units)
Figure 19. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2022)
Figure 20. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application in 2021
Figure 21. Alpha-1 Antitrypsin Drugs Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Company in 2021
Figure 23. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Geographic Region in 2021
Figure 25. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2017-2022)
Figure 26. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Country/Region in 2021
Figure 27. Americas Alpha-1 Antitrypsin Drugs Sales 2017-2022 (K Units)
Figure 28. Americas Alpha-1 Antitrypsin Drugs Revenue 2017-2022 ($ Millions)
Figure 29. APAC Alpha-1 Antitrypsin Drugs Sales 2017-2022 (K Units)
Figure 30. APAC Alpha-1 Antitrypsin Drugs Revenue 2017-2022 ($ Millions)
Figure 31. Europe Alpha-1 Antitrypsin Drugs Sales 2017-2022 (K Units)
Figure 32. Europe Alpha-1 Antitrypsin Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Americas Alpha-1 Antitrypsin Drugs Sales Market Share by Country in 2021
Figure 36. Americas Alpha-1 Antitrypsin Drugs Revenue Market Share by Country in 2021
Figure 37. United States Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Alpha-1 Antitrypsin Drugs Sales Market Share by Region in 2021
Figure 42. APAC Alpha-1 Antitrypsin Drugs Revenue Market Share by Regions in 2021
Figure 43. China Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Country in 2021
Figure 50. Europe Alpha-1 Antitrypsin Drugs Revenue Market Share by Country in 2021
Figure 51. Germany Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue Market Share by Country in 2021
Figure 58. Egypt Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Alpha-1 Antitrypsin Drugs in 2021
Figure 64. Manufacturing Process Analysis of Alpha-1 Antitrypsin Drugs
Figure 65. Industry Chain Structure of Alpha-1 Antitrypsin Drugs
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 1. Picture of Alpha-1 Antitrypsin Drugs
Figure 2. Alpha-1 Antitrypsin Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Alpha-1 Antitrypsin Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Alpha-1 Antitrypsin Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Alpha-1 Antitrypsin Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Parenteral
Figure 10. Product Picture of Inhalation
Figure 11. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type in 2021
Figure 12. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2017-2022)
Figure 13. Alpha-1 Antitrypsin Drugs Consumed in Drugstore
Figure 14. Global Alpha-1 Antitrypsin Drugs Market: Drugstore (2017-2022) & (K Units)
Figure 15. Alpha-1 Antitrypsin Drugs Consumed in Hospital
Figure 16. Global Alpha-1 Antitrypsin Drugs Market: Hospital (2017-2022) & (K Units)
Figure 17. Alpha-1 Antitrypsin Drugs Consumed in Others
Figure 18. Global Alpha-1 Antitrypsin Drugs Market: Others (2017-2022) & (K Units)
Figure 19. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2022)
Figure 20. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application in 2021
Figure 21. Alpha-1 Antitrypsin Drugs Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Company in 2021
Figure 23. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Geographic Region in 2021
Figure 25. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2017-2022)
Figure 26. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Country/Region in 2021
Figure 27. Americas Alpha-1 Antitrypsin Drugs Sales 2017-2022 (K Units)
Figure 28. Americas Alpha-1 Antitrypsin Drugs Revenue 2017-2022 ($ Millions)
Figure 29. APAC Alpha-1 Antitrypsin Drugs Sales 2017-2022 (K Units)
Figure 30. APAC Alpha-1 Antitrypsin Drugs Revenue 2017-2022 ($ Millions)
Figure 31. Europe Alpha-1 Antitrypsin Drugs Sales 2017-2022 (K Units)
Figure 32. Europe Alpha-1 Antitrypsin Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Americas Alpha-1 Antitrypsin Drugs Sales Market Share by Country in 2021
Figure 36. Americas Alpha-1 Antitrypsin Drugs Revenue Market Share by Country in 2021
Figure 37. United States Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Alpha-1 Antitrypsin Drugs Sales Market Share by Region in 2021
Figure 42. APAC Alpha-1 Antitrypsin Drugs Revenue Market Share by Regions in 2021
Figure 43. China Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Country in 2021
Figure 50. Europe Alpha-1 Antitrypsin Drugs Revenue Market Share by Country in 2021
Figure 51. Germany Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue Market Share by Country in 2021
Figure 58. Egypt Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Alpha-1 Antitrypsin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Alpha-1 Antitrypsin Drugs in 2021
Figure 64. Manufacturing Process Analysis of Alpha-1 Antitrypsin Drugs
Figure 65. Industry Chain Structure of Alpha-1 Antitrypsin Drugs
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
